Veterinary/Animal Vaccines Market by Type (Porcine, Poultry, Companion Animal, Aquaculture), Disease (Porcine Parvovirus, Swine Pneumonia, Avian Influenza, Rabies, Clostridial Diseases), Technology (Inactivated, Toxoid, Recombinant) - Global Forecast to 2022
“Veterinary Vaccines market is projected to register a CAGR of 5.9%”
The veterinary vaccines market is expected to reach USD 8.66 billion by 2022 from USD 6.50 billion in 2017, growing at a CAGR of 5.9% during the forecast period. Market growth can be attributed to factors such as growth in livestock population and repeated breakouts of livestock diseases; increasing adoption of companion animals; rising incidence of zoonotic diseases; initiatives by various government agencies, animal associations, and leading players; and the introduction of new types of vaccines in the market. On the other hand, the high storage cost for vaccines is expected to restrain the market to a certain extent.
“The companion animal vaccines segment is expected to grow at the highest rate during the forecast period”
On the basis of type, the veterinary vaccines market is segmented into porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines, and other vaccines. The companion animal vaccines segment is divided into canine vaccines and feline vaccines and in terms of value, the companion animal vaccines segment is expected grow at the highest CAGR during the forecast period. Increasing awareness about companion animal vaccination, rising prevalence of zoonotic diseases in humans, and the growing number of pets and increasing pet ownership are fueling the demand for these vaccines.
“The live attenuated vaccines segment is expected to account for the largest share of the market in 2017”
By technology, the market is classified into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines and other vaccines. In terms of value, the live attenuated vaccines segment is expected to account for the largest share of the market in 2017. The ease of administration and long-term immunity offered by the live attenuated vaccine technologies are driving the demand for this segment in the veterinary vaccines industry.
“Asia Pacific to provide significant growth opportunities during the forecast period”
Geographically, Europe is the largest market for veterinary vaccines market, followed by North America but the APAC region is expected to witness the highest growth in the forecast period. This growth is primarily attributed to rising pet adoption, expansion of key vaccine players in the region, and the wide range of product launches and investments in veterinary vaccines manufacturing facilities in the region, especially in India, China, and Thailand.
Break-up profile of primaries:
Research Coverage:
The veterinary vaccines market in this report is segmented by type, disease, technology, and region. The study tracks and analyzes competitive developments such as product launches; expansions; agreements, partnerships, and collaborations; and acquisitions. It also profiles the key players and their core competencies within the veterinary vaccines market.
Reasons to buy this report:
The report provides insights on the following pointers:
The veterinary vaccines market is expected to reach USD 8.66 billion by 2022 from USD 6.50 billion in 2017, growing at a CAGR of 5.9% during the forecast period. Market growth can be attributed to factors such as growth in livestock population and repeated breakouts of livestock diseases; increasing adoption of companion animals; rising incidence of zoonotic diseases; initiatives by various government agencies, animal associations, and leading players; and the introduction of new types of vaccines in the market. On the other hand, the high storage cost for vaccines is expected to restrain the market to a certain extent.
“The companion animal vaccines segment is expected to grow at the highest rate during the forecast period”
On the basis of type, the veterinary vaccines market is segmented into porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines, and other vaccines. The companion animal vaccines segment is divided into canine vaccines and feline vaccines and in terms of value, the companion animal vaccines segment is expected grow at the highest CAGR during the forecast period. Increasing awareness about companion animal vaccination, rising prevalence of zoonotic diseases in humans, and the growing number of pets and increasing pet ownership are fueling the demand for these vaccines.
“The live attenuated vaccines segment is expected to account for the largest share of the market in 2017”
By technology, the market is classified into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines and other vaccines. In terms of value, the live attenuated vaccines segment is expected to account for the largest share of the market in 2017. The ease of administration and long-term immunity offered by the live attenuated vaccine technologies are driving the demand for this segment in the veterinary vaccines industry.
“Asia Pacific to provide significant growth opportunities during the forecast period”
Geographically, Europe is the largest market for veterinary vaccines market, followed by North America but the APAC region is expected to witness the highest growth in the forecast period. This growth is primarily attributed to rising pet adoption, expansion of key vaccine players in the region, and the wide range of product launches and investments in veterinary vaccines manufacturing facilities in the region, especially in India, China, and Thailand.
Break-up profile of primaries:
- By Company Type- Tier 1-40%, Tier 2-35% and Tier 3-25%
- By Designation-C-level-33%, D-level-41% and Others-26%
- By Region-North America-35%, Europe-30%, Asia-21%, and RoW-14%
Research Coverage:
The veterinary vaccines market in this report is segmented by type, disease, technology, and region. The study tracks and analyzes competitive developments such as product launches; expansions; agreements, partnerships, and collaborations; and acquisitions. It also profiles the key players and their core competencies within the veterinary vaccines market.
Reasons to buy this report:
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on portfolios offered by the top players in the global veterinary vaccines market. The report analyzes the veterinary vaccines market by type, disease, technology, and region.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the veterinary vaccines market
- Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for veterinary vaccines across regions
- Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global veterinary vaccines market
- Competitive Assessment: In-depth assessment of, strategies, products, and manufacturing capabilities of the key players in the global veterinary vaccines market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primary interviews
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.3.1 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 GLOBAL VETERINARY VACCINES MARKET OVERVIEW
4.2 APAC VETERINARY VACCINES MARKET, BY TECHNOLOGY AND REGION
4.3 POULTRY VETERINARY VACCINES MARKET, BY DISEASE
4.4 VETERINARY VACCINES MARKET, BY GEOGRAPHY
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growth in livestock population and repeated outbreaks of livestock diseases
5.2.1.2 Increasing adoption of companion animals
5.2.1.3 Rising incidence of zoonotic diseases
5.2.1.4 Initiatives by various government agencies, animal associations, and leading players
5.2.1.5 Introduction of new types of vaccines
5.2.2 RESTRAINTS
5.2.2.1 High storage costs for vaccines
5.2.3 OPPORTUNITIES
5.2.3.1 Technological advancements
5.2.3.2 Growing awareness of animal health in emerging economies
5.2.4 CHALLENGE
5.2.4.1 Inadequate surveillance and reporting systems
6 VETERINARY VACCINES MARKET, BY TYPE
6.1 INTRODUCTION
6.2 PORCINE VACCINES
6.3 POULTRY VACCINES
6.4 LIVESTOCK VACCINES
6.4.1 BOVINE VACCINES
6.4.2 SMALL RUMINANT VACCINES
6.5 COMPANION ANIMAL VACCINES
6.5.1 CANINE VACCINES
6.5.2 FELINE VACCINES
6.6 AQUACULTURE VACCINES
6.7 OTHER ANIMAL VACCINES
7 VETERINARY VACCINES MARKET, BY DISEASE
7.1 INTRODUCTION
7.2 PORCINE
7.3 POULTRY
7.4 LIVESTOCK
7.4.1 BOVINE
7.4.2 SMALL RUMINANTS
7.5 COMPANION ANIMALS
7.5.1 CANINE
7.5.2 FELINE
7.6 AQUACULTURE
8 VETERINARY VACCINES MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
8.2 LIVE ATTENUATED VACCINES
8.3 INACTIVATED VACCINES
8.4 TOXOID VACCINES
8.5 RECOMBINANT VACCINES
8.6 OTHER VACCINES
9 VETERINARY VACCINES MARKET, BY REGION
9.1 INTRODUCTION
9.2 EUROPE
9.3 NORTH AMERICA
9.3.1 US
9.3.2 CANADA
9.4 ASIA PACIFIC (APAC)
9.4.1 CHINA
9.4.2 THAILAND
9.4.3 INDIA
9.4.4 REST OF APAC
9.5 REST OF THE WORLD
10 COMPETITIVE LANDSCAPE
10.1 MARKET RANKING ANALYSIS
11 COMPANY PROFILES
(BUSINESS OVERVIEW, PRODUCTS OFFERED, STRENGTH OF PRODUCT PORTFOLIO, BUSINESS STRATEGY EXCELLENCE, RECENT DEVELOPMENTS.)*
11.1 ZOETIS
11.2 MERCK ANIMAL HEALTH
11.3 BOEHRINGER INGELHEIM
11.4 ELANCO
11.5 CEVA
11.6 VIRBAC
11.7 VETOQUINOL
11.8 PHIBRO ANIMAL HEALTH
11.9 HESTER
11.10 HIPRA
11.11 IDT BIOLOGIKA
11.12 BIOGENESIS BAGO
11.13 TIANJIN RINGPU
11.14 CHINA ANIMAL HUSBANDRY
11.15 JINYU BIO-TECHNOLOGY
*Details on Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primary interviews
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.3.1 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 GLOBAL VETERINARY VACCINES MARKET OVERVIEW
4.2 APAC VETERINARY VACCINES MARKET, BY TECHNOLOGY AND REGION
4.3 POULTRY VETERINARY VACCINES MARKET, BY DISEASE
4.4 VETERINARY VACCINES MARKET, BY GEOGRAPHY
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growth in livestock population and repeated outbreaks of livestock diseases
5.2.1.2 Increasing adoption of companion animals
5.2.1.3 Rising incidence of zoonotic diseases
5.2.1.4 Initiatives by various government agencies, animal associations, and leading players
5.2.1.5 Introduction of new types of vaccines
5.2.2 RESTRAINTS
5.2.2.1 High storage costs for vaccines
5.2.3 OPPORTUNITIES
5.2.3.1 Technological advancements
5.2.3.2 Growing awareness of animal health in emerging economies
5.2.4 CHALLENGE
5.2.4.1 Inadequate surveillance and reporting systems
6 VETERINARY VACCINES MARKET, BY TYPE
6.1 INTRODUCTION
6.2 PORCINE VACCINES
6.3 POULTRY VACCINES
6.4 LIVESTOCK VACCINES
6.4.1 BOVINE VACCINES
6.4.2 SMALL RUMINANT VACCINES
6.5 COMPANION ANIMAL VACCINES
6.5.1 CANINE VACCINES
6.5.2 FELINE VACCINES
6.6 AQUACULTURE VACCINES
6.7 OTHER ANIMAL VACCINES
7 VETERINARY VACCINES MARKET, BY DISEASE
7.1 INTRODUCTION
7.2 PORCINE
7.3 POULTRY
7.4 LIVESTOCK
7.4.1 BOVINE
7.4.2 SMALL RUMINANTS
7.5 COMPANION ANIMALS
7.5.1 CANINE
7.5.2 FELINE
7.6 AQUACULTURE
8 VETERINARY VACCINES MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
8.2 LIVE ATTENUATED VACCINES
8.3 INACTIVATED VACCINES
8.4 TOXOID VACCINES
8.5 RECOMBINANT VACCINES
8.6 OTHER VACCINES
9 VETERINARY VACCINES MARKET, BY REGION
9.1 INTRODUCTION
9.2 EUROPE
9.3 NORTH AMERICA
9.3.1 US
9.3.2 CANADA
9.4 ASIA PACIFIC (APAC)
9.4.1 CHINA
9.4.2 THAILAND
9.4.3 INDIA
9.4.4 REST OF APAC
9.5 REST OF THE WORLD
10 COMPETITIVE LANDSCAPE
10.1 MARKET RANKING ANALYSIS
11 COMPANY PROFILES
(BUSINESS OVERVIEW, PRODUCTS OFFERED, STRENGTH OF PRODUCT PORTFOLIO, BUSINESS STRATEGY EXCELLENCE, RECENT DEVELOPMENTS.)*
11.1 ZOETIS
11.2 MERCK ANIMAL HEALTH
11.3 BOEHRINGER INGELHEIM
11.4 ELANCO
11.5 CEVA
11.6 VIRBAC
11.7 VETOQUINOL
11.8 PHIBRO ANIMAL HEALTH
11.9 HESTER
11.10 HIPRA
11.11 IDT BIOLOGIKA
11.12 BIOGENESIS BAGO
11.13 TIANJIN RINGPU
11.14 CHINA ANIMAL HUSBANDRY
11.15 JINYU BIO-TECHNOLOGY
*Details on Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
LIST OF TABLES
Table 1 GLOBAL LIVESTOCK ANIMAL POPULATION, 2000 AND 2013
Table 2 ANIMAL DISEASE OUTBREAKS REPORTED IN RECENT YEARS
Table 3 PERCENTAGE OF PET OWNERSHIP, BY COUNTRY, 2016
Table 4 SMALL COMPANION ANIMAL POPULATION, BY COUNTRY, 2014 VS. 2016 (MILLION)
Table 5 VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 6 PORCINE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 7 NORTH AMERICA: PORCINE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 8 ASIA PACIFIC: PORCINE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 9 POULTRY VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 10 NORTH AMERICA: POULTRY VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 11 ASIA PACIFIC: POULTRY VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 12 LIVESTOCK VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 13 NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 14 ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 15 LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 16 BOVINE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 17 NORTH AMERICA: BOVINE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 18 ASIA PACIFIC: BOVINE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 19 SMALL RUMINANT VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 20 NORTH AMERICA: SMALL RUMINANT VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 21 ASIA PACIFIC: SMALL RUMINANT VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 22 COMPANION ANIMAL VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 23 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 24 ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 25 COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 26 CANINE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 27 NORTH AMERICA: CANINE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 28 ASIA PACIFIC: CANINE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 29 FELINE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 30 NORTH AMERICA: FELINE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 31 ASIA PACIFIC: FELINE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 32 AQUACULTURE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 33 NORTH AMERICA: AQUACULTURE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 34 OTHER ANIMAL VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 35 NORTH AMERICA: OTHER ANIMAL VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 36 PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 37 PORCINE CIRCOVIRUS II VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 38 NORTH AMERICA: PORCINE CIRCOVIRUS II VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 39 ASIA PACIFIC: PORCINE CIRCOVIRUS II VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 40 PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 41 NORTH AMERICA: PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 42 ASIA PACIFIC: PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 43 PORCINE PARVOVIRUS VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 44 NORTH AMERICA: PORCINE PARVOVIRUS VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 45 ASIA PACIFIC: PORCINE PARVOVIRUS VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 46 POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 47 INFECTIOUS BRONCHITIS VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 48 NORTH AMERICA: INFECTIOUS BRONCHITIS VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 49 ASIA PACIFIC: INFECTIOUS BRONCHITIS VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 50 AVIAN INFLUENZA VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 51 NORTH AMERICA: AVIAN INFLUENZA VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 52 ASIA PACIFIC: AVIAN INFLUENZA VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 53 NEWCASTLE DISEASE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 54 NORTH AMERICA: NEWCASTLE DISEASE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 55 ASIA PACIFIC: NEWCASTLE DISEASE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 56 BOVINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 57 FOOT-AND-MOUTH DISEASE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 58 BOVINE VIRAL DIARRHEA VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 59 BOVINE CLOSTRIDIAL DISEASE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 60 BRUCELLOSIS VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 61 SMALL RUMINANT VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 62 CANINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 63 FELINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 64 AQUACULTURE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 65 VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 66 LIVE ATTENUATED VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 67 NORTH AMERICA: LIVE ATTENUATED VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 68 ASIA PACIFIC: LIVE ATTENUATED VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 69 INACTIVATED VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 70 NORTH AMERICA: INACTIVATED VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 71 ASIA PACIFIC: INACTIVATED VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 72 TOXOID VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 73 NORTH AMERICA: TOXOID VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 74 ASIA PACIFIC: TOXOID VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 75 RECOMBINANT VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 76 NORTH AMERICA: RECOMBINANT VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 77 ASIA PACIFIC: RECOMBINANT VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 78 OTHER VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 79 NORTH AMERICA: OTHER VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 80 ASIA PACIFIC: OTHER VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 81 VETERINARY VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 82 EUROPE: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 83 EUROPE: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 84 EUROPE: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 85 EUROPE: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 86 EUROPE: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 87 EUROPE: BOVINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 88 EUROPE: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 89 NORTH AMERICA: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 90 NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 91 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 92 NORTH AMERICA: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 93 NORTH AMERICA: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 94 NORTH AMERICA: BOVINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 95 NORTH AMERICA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 96 NORTH AMERICA: VETERINARY VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 97 US: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 98 US: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 99 US: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 100 US: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 101 US: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 102 US: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 103 CANADA: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 104 CANADA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 105 CANADA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 106 CANADA: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 107 CANADA: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 108 CANADA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 109 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 110 ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 111 ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 112 ASIA PACIFIC: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 113 ASIA PACIFIC: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 114 ASIA PACIFIC: BOVINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 115 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 116 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 117 CHINA: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 118 CHINA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 119 CHINA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 120 CHINA: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 121 CHINA: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 122 CHINA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 123 THAILAND: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 124 THAILAND: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 125 THAILAND: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 126 THAILAND: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 127 THAILAND: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 128 THAILAND: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 129 INDIA: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 130 INDIA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 131 INDIA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 132 INDIA: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 133 INDIA: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 134 INDIA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 135 ROAPAC: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 136 ROAPAC: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 137 ROAPAC: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 138 ROAPAC: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 139 ROAPAC: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 140 ROAPAC: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 141 ROW: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 142 ROW: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 143 ROW: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 144 ROW: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 145 ROW: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 146 ROW: BOVINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 147 ROW: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 148 RANK OF COMPANIES IN THE VETERINARY VACCINES MARKET, 2017
Table 1 GLOBAL LIVESTOCK ANIMAL POPULATION, 2000 AND 2013
Table 2 ANIMAL DISEASE OUTBREAKS REPORTED IN RECENT YEARS
Table 3 PERCENTAGE OF PET OWNERSHIP, BY COUNTRY, 2016
Table 4 SMALL COMPANION ANIMAL POPULATION, BY COUNTRY, 2014 VS. 2016 (MILLION)
Table 5 VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 6 PORCINE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 7 NORTH AMERICA: PORCINE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 8 ASIA PACIFIC: PORCINE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 9 POULTRY VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 10 NORTH AMERICA: POULTRY VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 11 ASIA PACIFIC: POULTRY VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 12 LIVESTOCK VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 13 NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 14 ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 15 LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 16 BOVINE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 17 NORTH AMERICA: BOVINE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 18 ASIA PACIFIC: BOVINE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 19 SMALL RUMINANT VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 20 NORTH AMERICA: SMALL RUMINANT VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 21 ASIA PACIFIC: SMALL RUMINANT VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 22 COMPANION ANIMAL VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 23 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 24 ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 25 COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 26 CANINE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 27 NORTH AMERICA: CANINE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 28 ASIA PACIFIC: CANINE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 29 FELINE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 30 NORTH AMERICA: FELINE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 31 ASIA PACIFIC: FELINE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 32 AQUACULTURE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 33 NORTH AMERICA: AQUACULTURE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 34 OTHER ANIMAL VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 35 NORTH AMERICA: OTHER ANIMAL VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 36 PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 37 PORCINE CIRCOVIRUS II VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 38 NORTH AMERICA: PORCINE CIRCOVIRUS II VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 39 ASIA PACIFIC: PORCINE CIRCOVIRUS II VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 40 PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 41 NORTH AMERICA: PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 42 ASIA PACIFIC: PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 43 PORCINE PARVOVIRUS VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 44 NORTH AMERICA: PORCINE PARVOVIRUS VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 45 ASIA PACIFIC: PORCINE PARVOVIRUS VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 46 POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 47 INFECTIOUS BRONCHITIS VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 48 NORTH AMERICA: INFECTIOUS BRONCHITIS VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 49 ASIA PACIFIC: INFECTIOUS BRONCHITIS VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 50 AVIAN INFLUENZA VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 51 NORTH AMERICA: AVIAN INFLUENZA VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 52 ASIA PACIFIC: AVIAN INFLUENZA VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 53 NEWCASTLE DISEASE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 54 NORTH AMERICA: NEWCASTLE DISEASE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 55 ASIA PACIFIC: NEWCASTLE DISEASE VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 56 BOVINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 57 FOOT-AND-MOUTH DISEASE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 58 BOVINE VIRAL DIARRHEA VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 59 BOVINE CLOSTRIDIAL DISEASE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 60 BRUCELLOSIS VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 61 SMALL RUMINANT VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 62 CANINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 63 FELINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 64 AQUACULTURE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 65 VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 66 LIVE ATTENUATED VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 67 NORTH AMERICA: LIVE ATTENUATED VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 68 ASIA PACIFIC: LIVE ATTENUATED VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 69 INACTIVATED VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 70 NORTH AMERICA: INACTIVATED VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 71 ASIA PACIFIC: INACTIVATED VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 72 TOXOID VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 73 NORTH AMERICA: TOXOID VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 74 ASIA PACIFIC: TOXOID VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 75 RECOMBINANT VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 76 NORTH AMERICA: RECOMBINANT VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 77 ASIA PACIFIC: RECOMBINANT VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 78 OTHER VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 79 NORTH AMERICA: OTHER VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 80 ASIA PACIFIC: OTHER VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 81 VETERINARY VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 82 EUROPE: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 83 EUROPE: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 84 EUROPE: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 85 EUROPE: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 86 EUROPE: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 87 EUROPE: BOVINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 88 EUROPE: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 89 NORTH AMERICA: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 90 NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 91 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 92 NORTH AMERICA: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 93 NORTH AMERICA: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 94 NORTH AMERICA: BOVINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 95 NORTH AMERICA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 96 NORTH AMERICA: VETERINARY VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 97 US: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 98 US: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 99 US: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 100 US: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 101 US: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 102 US: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 103 CANADA: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 104 CANADA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 105 CANADA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 106 CANADA: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 107 CANADA: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 108 CANADA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 109 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 110 ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 111 ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 112 ASIA PACIFIC: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 113 ASIA PACIFIC: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 114 ASIA PACIFIC: BOVINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 115 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 116 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 117 CHINA: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 118 CHINA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 119 CHINA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 120 CHINA: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 121 CHINA: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 122 CHINA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 123 THAILAND: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 124 THAILAND: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 125 THAILAND: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 126 THAILAND: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 127 THAILAND: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 128 THAILAND: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 129 INDIA: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 130 INDIA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 131 INDIA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 132 INDIA: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 133 INDIA: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 134 INDIA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 135 ROAPAC: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 136 ROAPAC: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 137 ROAPAC: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 138 ROAPAC: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 139 ROAPAC: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 140 ROAPAC: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 141 ROW: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 142 ROW: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 143 ROW: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 144 ROW: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 145 ROW: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 146 ROW: BOVINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION)
Table 147 ROW: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
Table 148 RANK OF COMPANIES IN THE VETERINARY VACCINES MARKET, 2017
LIST OF FIGURES
Figure 1 RESEARCH DESIGN: VETERINARY VACCINES MARKET
Figure 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
Figure 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 VETERINARY VACCINES MARKET, BY TYPE, 2017 VS. 2022
Figure 7 VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017 VS. 2022
Figure 8 PORCINE VACCINES MARKET, BY DISEASE, 2017 VS. 2022
Figure 9 VETERINARY VACCINES MARKET, BY REGION
Figure 10 GROWTH IN LIVESTOCK POPULATION AND REPEATED BREAKOUTS OF LIVESTOCK DISEASES ARE DRIVING THE VETERINARY VACCINES MARKET
Figure 11 LIVE ATTENUATED VACCINES SEGMENT IS ESTIMATED TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2017
Figure 12 INFECTIOUS BRONCHITIS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2017 AND 2022
Figure 13 APAC IS EXPECTED TO HAVE THE FASTEST CAGR DURING THE FORECAST PERIOD
Figure 14 VETERINARY VACCINES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
Figure 15 PORCINE VACCINES SEGMENT TO DOMINATE THE VETERINARY VACCINES MARKET IN 2017
Figure 16 LIVE ATTENUATED VACCINES SEGMENT TO DOMINATE THE VETERINARY VACCINES MARKET IN 2022
Figure 17 GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
Figure 18 EUROPE: VETERINARY VACCINES MARKET SNAPSHOT
Figure 19 ASIA PACIFIC: VETERINARY VACCINES MARKET SNAPSHOT
Figure 20 ZOETIS: COMPANY SNAPSHOT (2016)
Figure 21 MERCK & CO. INC.: COMPANY SNAPSHOT (2016)
Figure 22 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT (2016)
Figure 23 ELANCO: COMPANY SNAPSHOT (2016)
Figure 24 CEVA: COMPANY SNAPSHOT (2016)
Figure 25 VIRBAC: COMPANY SNAPSHOT (2016)
Figure 1 RESEARCH DESIGN: VETERINARY VACCINES MARKET
Figure 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
Figure 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 VETERINARY VACCINES MARKET, BY TYPE, 2017 VS. 2022
Figure 7 VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017 VS. 2022
Figure 8 PORCINE VACCINES MARKET, BY DISEASE, 2017 VS. 2022
Figure 9 VETERINARY VACCINES MARKET, BY REGION
Figure 10 GROWTH IN LIVESTOCK POPULATION AND REPEATED BREAKOUTS OF LIVESTOCK DISEASES ARE DRIVING THE VETERINARY VACCINES MARKET
Figure 11 LIVE ATTENUATED VACCINES SEGMENT IS ESTIMATED TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2017
Figure 12 INFECTIOUS BRONCHITIS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2017 AND 2022
Figure 13 APAC IS EXPECTED TO HAVE THE FASTEST CAGR DURING THE FORECAST PERIOD
Figure 14 VETERINARY VACCINES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
Figure 15 PORCINE VACCINES SEGMENT TO DOMINATE THE VETERINARY VACCINES MARKET IN 2017
Figure 16 LIVE ATTENUATED VACCINES SEGMENT TO DOMINATE THE VETERINARY VACCINES MARKET IN 2022
Figure 17 GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
Figure 18 EUROPE: VETERINARY VACCINES MARKET SNAPSHOT
Figure 19 ASIA PACIFIC: VETERINARY VACCINES MARKET SNAPSHOT
Figure 20 ZOETIS: COMPANY SNAPSHOT (2016)
Figure 21 MERCK & CO. INC.: COMPANY SNAPSHOT (2016)
Figure 22 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT (2016)
Figure 23 ELANCO: COMPANY SNAPSHOT (2016)
Figure 24 CEVA: COMPANY SNAPSHOT (2016)
Figure 25 VIRBAC: COMPANY SNAPSHOT (2016)
